Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Ichihashi et al reported that 43% of patients had antipsychotic polypharmacy. Number of antipsychotics used in patients with schizophrenia in Japan was the greatest among Asian countries. However, the antipsychotic polypharmacy rate in Japan decreased gradually. Recent systematic review, meta‐analysis and meta‐regression analysis demonstrated that...
Alternative Titles
Full title
Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_dd89e395c154424b9609b66dd80f1657
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dd89e395c154424b9609b66dd80f1657
Other Identifiers
ISSN
2574-173X
E-ISSN
2574-173X
DOI
10.1002/npr2.12127
